Lataa...
Discovery of LDD-1075 as a potent FLT3 inhibitor
Fms-like tyrosine kinase 3 (FLT3) is a valuable pharmacological target in the treatment of acute myeloid leukemia (AML). LDD-1075 and LDD-1076 are indirubin derivatives, and LDD-1075 is the ester form of LDD-1076. LDD-1076 exhibited a potent in vitro FLT3 kinase activity inhibition with an IC(50) of...
Tallennettuna:
| Julkaisussa: | Oncol Lett |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6444428/ https://ncbi.nlm.nih.gov/pubmed/30944659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10096 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|